News
3d
MedPage Today on MSNTruly Novel RA Drug Passes Mid-Stage TestPatients were in their early 50s on average, and some 80% were women. Nearly all were white (most participants were from ...
The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
The FDA announced a shift away from animal testing for drug approval, citing advanced alternatives like AI and organoids ...
The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...
The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...
The U.S. Food and Drug Administration announced it is shifting away from animal testing in the development of monoclonal ...
The move comes after lawmakers sought to force the agency to update regulations that would allow alternatives to animal ...
On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy over its use of non-human primates, plunged 28 percent after the FDA issued ...
Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results